EPISODE · Aug 29, 2024 · 37 MIN
320: Jim Wilson's next venture, a surprise startup shutdown, & Lilly's Zepbound strategy
from The Readout Loud · host STAT
STAT biotech reporter Jonathan Wosen joins us to discuss gene therapy pioneer Jim Wilson's exit from his decades-long tenure at the University of Pennsylvania. We also discuss the latest news in the life sciences, including the surprising collapse of a gene editing company, Eli Lilly's pitch to consumers, and more.
Embed this episode
NOW PLAYING
320: Jim Wilson's next venture, a surprise startup shutdown, & Lilly's Zepbound strategy
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.